A clinical and biochemical study of a trial of iproniazid in the treatment of depression.

Abstract

Iproniazid (isopropylisonicotinic acid hydrazide) is a compound with a marked antibacterial action against M. tuberculosis. Although a number of clinical trials have shown it to be effective against tuberculosis, side-effects are common, so that it has been largely superseded by the relatively nontoxic compound, isoniazid. As one of the more frequent of… (More)

Topics

5 Figures and Tables